Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

Data as of Apr 17
 -0.46 / -3.30%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.

Contact Information

Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York New York 10022
P:(212) 531-5965
Investor Relations:



Mutual fund holders29.84%
Other institutional28.12%
Individual stakeholders16.53%

Top Executives

Ronald BentsurChief Executive Officer & Director
Gregory P. MadisonChief Operating Officer & Executive Vice President
James F. OlivieroCFO, Secretary, Treasurer & CAO
Amit SharmaVice President-Medical Affairs
Douglass H. LaidlawDirector-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.